PEPCID Side Effects

6736387-4 | Hepatic Neoplasm Malignant, Large Intestine Carcinoma
on May 07, 2010 Male patient from JAPAN , 70 years of age, weighting 136.7 lb, was diagnosed with malaise and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant, large intestine carcinoma. Pepcid dosage: . During the same period patient was treated with HOCHU EKKI TO (View Hochu-ekki-to Review and Hochu-ekki-to Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6728030-5 | Hepatic Neoplasm Malignant, Large Intestine Carcinoma
Patient was taking Pepcid (View Usage). Patient had the following side effects: hepatic neoplasm malignant, large intestine carcinoma on May 07, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 136.7 lb, was diagnosed with malaise and. Pepcid dosage: . During the same period patient was treated with HOCHU EKKI TO (View Hochu-ekki-to Review and Hochu-ekki-to Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ).

6713850-3 | Pancreatitis Acute
Adverse event was reported on Apr 28, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with gastritis, bone marrow transplant (What is bone marrow transplant?) and. Location: JAPAN , 13 years of age, weighting 88.18 lb, After Pepcid was administered, patient had the following side effects: pancreatitis acute. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CLAFORAN (View Claforan Review and Claforan Label ), FUNGUARD (View Funguard Review and Funguard Label ), MESTRANOL AND NORETHINDRONE (View Mestranol And Norethindrone Review and Mestranol And Norethindrone Label ).

6711900-1 | Liver Disorder
on Apr 23, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with secondary hyperthyroidism, alcoholic liver disease and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Pepcid dosage: . During the same period patient was treated with CINACALCET (View Cinacalcet Review and Cinacalcet Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), SEVELAMER HYDROCHLORIDE (View Sevelamer Hydrochloride Review and Sevelamer Hydrochloride Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).


6710071-5 | Liver Disorder
on Apr 23, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with secondary hyperthyroidism, alcoholic liver disease and was treated with Pepcid (View Usage). Patient had the following side effects: liver disorder. Pepcid dosage: . During the same period patient was treated with CINACALCET (View Cinacalcet Review and Cinacalcet Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), SEVELAMER HYDROCHLORIDE (View Sevelamer Hydrochloride Review and Sevelamer Hydrochloride Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6704362-1 | Systemic Lupus Erythematosus
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: systemic lupus erythematosus on Apr 26, 2010 from JAPAN Additional patient health information: Male patient , 93 years of age, . Pepcid dosage: . During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ).

6694574-8 | Pancreatitis Acute
Adverse event was reported on Apr 14, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with gastritis, bone marrow transplant (What is bone marrow transplant?) and. Location: JAPAN , 13 years of age, weighting 88.18 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis acute. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CLAFORAN (View Claforan Review and Claforan Label ), FUNGUARD (View Funguard Review and Funguard Label ), MESTRANOL AND NORETHINDRONE (View Mestranol And Norethindrone Review and Mestranol And Norethindrone Label ).

6675017-7 | Erythema Multiforme
on Apr 02, 2010 Female patient from JAPAN , 44 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: erythema multiforme. Pepcid dosage: .

6659770-4 | Laryngeal Oedema
on Mar 25, 2010 Female patient from JAPAN , 57 years of age, weighting 79.37 lb, was diagnosed with gastritis, osteoporosis (What is osteoporosis?), depression (What is depression?), neoplasm malignant, constipation (What is constipation?), hypovitaminosis, insomnia and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: laryngeal oedema. Pepcid dosage: . During the same period patient was treated with ONEALFA (View Onealfa Review and Onealfa Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), DUROTEP (View Durotep Review and Durotep Label ), MAGMITT (View Magmitt Review and Magmitt Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MYSLEE (View Myslee Review and Myslee Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

6653681-6 | Gastritis, Gastrooesophageal Reflux Disease
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis, gastrooesophageal reflux disease on Mar 12, 2010 from CANADA Additional patient health information: Female patient , weighting 180.8 lb, . Pepcid dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), PARIET (View Pariet Review and Pariet Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6645381-3 | Overdose, Restlessness
Adverse event was reported on Mar 15, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with gastritis prophylaxis, hypertension and. Location: JAPAN , 85 years of age, Patient had the following side effects: overdose, restlessness. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SEPAMIT R (View Sepamit R Review and Sepamit R Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), MYSLEE (View Myslee Review and Myslee Label ).

6642767-8 | Breast Cancer Male, Gynaecomastia
on Mar 05, 2010 Male patient from JAPAN , 60 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: breast cancer male, gynaecomastia. Pepcid dosage: Po.

6642643-0 | Gastritis, Gastrooesophageal Reflux Disease
on Mar 12, 2010 Female patient from CANADA , weighting 180.8 lb, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis, gastrooesophageal reflux disease. Pepcid dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), PARIET (View Pariet Review and Pariet Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6640527-5 | Sinus Arrest, Sinus Bradycardia
Patient was taking Pepcid (View Usage). Patient had the following side effects: sinus arrest, sinus bradycardia on Mar 11, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, . Pepcid dosage: . During the same period patient was treated with NEOPHAGEN INJECTION (View Neophagen Injection Review and Neophagen Injection Label ), PANTOL (View Pantol Review and Pantol Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FUNGUARD (View Funguard Review and Funguard Label ), ERYTHROCIN LACTOBIONATE (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), MARZULENE (View Marzulene Review and Marzulene Label ).

6637405-4 | Restlessness
Adverse event was reported on Mar 08, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 85 years of age, After Pepcid was administered, patient had the following side effects: restlessness. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SEPAMIT R (View Sepamit R Review and Sepamit R Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), MYSLEE (View Myslee Review and Myslee Label ).

6636624-0 | Laryngeal Oedema
on Mar 09, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with gastritis, osteoporosis (What is osteoporosis?), depression (What is depression?), neoplasm malignant, constipation (What is constipation?), hypovitaminosis, insomnia and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal oedema. Pepcid dosage: . During the same period patient was treated with ONEALFA (View Onealfa Review and Onealfa Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), DUROTEP (View Durotep Review and Durotep Label ), MAGMITT (View Magmitt Review and Magmitt Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MYSLEE (View Myslee Review and Myslee Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

6635736-5 | Breast Cancer Male, Gynaecomastia
on Feb 26, 2010 Male patient from JAPAN , 60 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: breast cancer male, gynaecomastia. Pepcid dosage: Po.

6632379-4 | Hepatic Function Abnormal, Rhabdomyolysis
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: hepatic function abnormal, rhabdomyolysis on Mar 05, 2010 from JAPAN Additional patient health information: Male patient , 20 years of age, weighting 66.14 lb, was diagnosed with psychosomatic disease, spastic paralysis and. Pepcid dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), CERCINE (View Cercine Review and Cercine Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), ELENTAL (View Elental Review and Elental Label ), ENSURE (View Ensure Review and Ensure Label ). Patient was hospitalized.

6618557-9 | Hypokalaemia, Hyponatraemia
Adverse event was reported on Feb 26, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with pneumonia aspiration, cerebral infarction and. Location: JAPAN , 83 years of age, Patient experienced the following unwanted or unexpected effects: hypokalaemia, hyponatraemia. During the same period patient was treated with PRIMPERAN (View Primperan Review and Primperan Label ), UNASYN (View Unasyn Review and Unasyn Label ), GLYCEOL (FRUCTOSE (+) GLYCERIN (+) SODIUM CHLORIDE) (View Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Review and Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Label ), OZAPEN (View Ozapen Review and Ozapen Label ). Patient was hospitalized.

6600536-9 | Gastritis Fungal
on Feb 15, 2010 Male patient from JAPAN , 85 years of age, was diagnosed with gastritis and was treated with Pepcid (View Usage). Patient had the following side effects: gastritis fungal. Pepcid dosage: .

6597784-3 | Blood Chloride Decreased, Blood Creatine Phosphokinase Decreased, Brain Natriuretic Peptide Increased, Chest Discomfort, Haematocrit Decreased, Haemoglobin Decreased, Hypertensive Emergency, Left Atrial Dilatation, Non-cardiac Chest Pain
on Feb 08, 2010 Male patient from UNITED STATES , 31 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: blood chloride decreased, blood creatine phosphokinase decreased, brain natriuretic peptide increased, chest discomfort, haematocrit decreased, haemoglobin decreased, hypertensive emergency, left atrial dilatation, non-cardiac chest pain. Pepcid dosage: 20 Mg/bid/po. During the same period patient was treated with CINACALCET HYDROCHLORIDE UNK (/po) (View Cinacalcet Hydrochloride Unk Review and Cinacalcet Hydrochloride Unk Label ), NEXIUM (View Nexium Review and Nexium Label ), TUMS (View Tums Review and Tums Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6597752-1 | Hypokalaemia, Hyponatraemia
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, hyponatraemia on Feb 16, 2010 from JAPAN Additional patient health information: Male patient , 83 years of age, was diagnosed with pneumonia aspiration, cerebral infarction and. Pepcid dosage: . During the same period patient was treated with PRIMPERAN (View Primperan Review and Primperan Label ), UNASYN (View Unasyn Review and Unasyn Label ), GLYCEOL (FRUCTOSE (+) GLYCERIN (+) SODIUM CHLORIDE) (View Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Review and Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Label ), OZAPEN (View Ozapen Review and Ozapen Label ). Patient was hospitalized.

6596752-5 | Long Qt Syndrome, Torsade De Pointes
Adverse event was reported on Jan 12, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 80 years of age, Patient had the following side effects: long qt syndrome, torsade de pointes. During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ).

6594229-4 | Sinus Arrest, Sinus Bradycardia
on Feb 15, 2010 Male patient from JAPAN , 63 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: sinus arrest, sinus bradycardia. Pepcid dosage: . During the same period patient was treated with NEOPHAGEN INJECTION (View Neophagen Injection Review and Neophagen Injection Label ), PANTOL (View Pantol Review and Pantol Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FUNGUARD (View Funguard Review and Funguard Label ), ERYTHROMYCIN ETHYLSUCCINATE (View Erythromycin Ethylsuccinate Review and Erythromycin Ethylsuccinate Label ), MARZULENE (View Marzulene Review and Marzulene Label ).

6589041-6 | Gastritis Fungal
on Feb 08, 2010 Male patient from JAPAN , 85 years of age, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis fungal. Pepcid dosage: .

6583113-8 | Hyponatraemia, Rhabdomyolysis
Patient was taking Pepcid (View Usage). Patient had the following side effects: hyponatraemia, rhabdomyolysis on Jan 18, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with biliary cirrhosis primary and. Pepcid dosage: . During the same period patient was treated with BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6580703-3 | Sinus Arrest, Sinus Bradycardia
Adverse event was reported on Feb 05, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 63 years of age, After Pepcid was administered, patient had the following side effects: sinus arrest, sinus bradycardia. During the same period patient was treated with NEOPHAGEN INJECTION (View Neophagen Injection Review and Neophagen Injection Label ), PANTOL (View Pantol Review and Pantol Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FUNGUARD (View Funguard Review and Funguard Label ), ERYTHROMYCIN ETHYLSUCCINATE (View Erythromycin Ethylsuccinate Review and Erythromycin Ethylsuccinate Label ), MARZULENE (View Marzulene Review and Marzulene Label ).

6575665-9 | Hepatic Function Abnormal, Rhabdomyolysis
on Jan 29, 2010 Male patient from JAPAN , 20 years of age, weighting 66.14 lb, was diagnosed with psychosomatic disease, spastic paralysis and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, rhabdomyolysis. Pepcid dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), CERCINE (View Cercine Review and Cercine Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), ELENTAL (View Elental Review and Elental Label ), ENSURE (View Ensure Review and Ensure Label ). Patient was hospitalized.

6574377-5 | Altered State Of Consciousness, Fall, Subdural Haemorrhage
on Jan 05, 2010 Female patient from JAPAN , 74 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: altered state of consciousness, fall (What is fall?), subdural haemorrhage. Pepcid dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), EPINASTINE HYDROCHLORIDE (View Epinastine Hydrochloride Review and Epinastine Hydrochloride Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TEMOCAPRIL HYDROCHLORIDE (View Temocapril Hydrochloride Review and Temocapril Hydrochloride Label ), MEXILETINE HYDROCHLORIDE (View Mexiletine Hydrochloride Review and Mexiletine Hydrochloride Label ).

6572482-0 | Bradycardia, Cardiac Arrest
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?) on Jan 27, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, . Pepcid dosage: .

6566995-5 | Haematuria, Renal Failure, Renal Impairment
Adverse event was reported on Jan 25, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with oesophageal carcinoma, pneumonia (What is pneumonia?), pseudomonas infection, inflammation and. Location: JAPAN , 77 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: haematuria, renal failure, renal impairment. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), FLUMARIN (View Flumarin Review and Flumarin Label ), FINIBAX (View Finibax Review and Finibax Label ), MODACIN (View Modacin Review and Modacin Label ), FUNGUARD (View Funguard Review and Funguard Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6565076-4 | Hyponatraemia, Rhabdomyolysis
on Jan 18, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with biliary cirrhosis primary and was treated with Pepcid (View Usage). Patient had the following side effects: hyponatraemia, rhabdomyolysis. Pepcid dosage: . During the same period patient was treated with BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6559163-4 | Hypokalaemia, Hyponatraemia
on Jan 20, 2010 Male patient from JAPAN , 83 years of age, was diagnosed with pneumonia aspiration and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: hypokalaemia, hyponatraemia. Pepcid dosage: . During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), UNASYN (View Unasyn Review and Unasyn Label ), GLYCEOL (FRUCTOSE (+) GLYCERIN (+) SODIUM CHLORIDE) (View Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Review and Glyceol (fructose (+) Glycerin (+) Sodium Chloride) Label ), OZAPEN (View Ozapen Review and Ozapen Label ). Patient was hospitalized.

6556482-2 | Rhabdomyolysis
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Jan 18, 2010 from JAPAN Additional patient health information: Male patient , 25 years of age, was diagnosed with prophylaxis, pain (What is pain?), hepatic neoplasm malignant, pyrexia, infection (What is infection?) and. Pepcid dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GELATIN (View Gelatin Review and Gelatin Label ), LEPETAN (View Lepetan Review and Lepetan Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), GLUTATHIONE (View Glutathione Review and Glutathione Label ), PANSPORIN (View Pansporin Review and Pansporin Label ).

6556478-0 | Hyponatraemia, Rhabdomyolysis
Adverse event was reported on Jan 18, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with biliary cirrhosis primary and. Location: JAPAN , 57 years of age, Patient had the following side effects: hyponatraemia, rhabdomyolysis. During the same period patient was treated with BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6552204-X | Atrial Fibrillation, Bradycardia, Long Qt Syndrome, Torsade De Pointes, Ventricular Extrasystoles
on Jan 12, 2010 Male patient from JAPAN , 80 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, long qt syndrome, torsade de pointes, ventricular extrasystoles. Pepcid dosage: . During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ).

6547140-9 | Long Qt Syndrome
on Jan 12, 2010 Male patient from JAPAN , 80 years of age, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: long qt syndrome. Pepcid dosage: . During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ).

6545335-1 | Rhabdomyolysis
Patient was taking Pepcid (View Usage). Patient had the following side effects: rhabdomyolysis on Jan 11, 2010 from JAPAN Additional patient health information: Male patient , 25 years of age, was diagnosed with prophylaxis, pain (What is pain?), hepatic neoplasm malignant, pyrexia, infection (What is infection?) and. Pepcid dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GELATIN (View Gelatin Review and Gelatin Label ), LEPETAN (View Lepetan Review and Lepetan Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), GLUTATHIONE (View Glutathione Review and Glutathione Label ), PANSPORIN (View Pansporin Review and Pansporin Label ).

6540373-7 | Stevens-johnson Syndrome
Adverse event was reported on Jan 06, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with pyrexia, cerebral haemorrhage and. Location: JAPAN , 61 years of age, After Pepcid was administered, patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ).

6539728-6 | Rhabdomyolysis
on Jan 11, 2010 Male patient from JAPAN , 25 years of age, was diagnosed with prophylaxis, pain (What is pain?), hepatic neoplasm malignant, pyrexia, infection (What is infection?) and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Pepcid dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), GELATIN (View Gelatin Review and Gelatin Label ), LEPETAN (View Lepetan Review and Lepetan Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), GLUTATHIONE (View Glutathione Review and Glutathione Label ), PANSPORIN (View Pansporin Review and Pansporin Label ).

6538497-3 | Dyspnoea, Urticaria
on Jan 08, 2010 Female patient from JAPAN , 19 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: dyspnoea, urticaria. Pepcid dosage: . During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), HARTMANN SOLUTION KOBAYASHI (View Hartmann Solution Kobayashi Review and Hartmann Solution Kobayashi Label ).

6536446-5 | Altered State Of Consciousness, Fall, Subdural Haemorrhage
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: altered state of consciousness, fall (What is fall?), subdural haemorrhage on Jan 05, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, . Pepcid dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), EPINASTINE HYDROCHLORIDE (View Epinastine Hydrochloride Review and Epinastine Hydrochloride Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TEMOCAPRIL HYDROCHLORIDE (View Temocapril Hydrochloride Review and Temocapril Hydrochloride Label ), MEXILETINE HYDROCHLORIDE (View Mexiletine Hydrochloride Review and Mexiletine Hydrochloride Label ).

6519949-9 | Angioedema
Adverse event was reported on Jan 30, 2009 by a Female patient taking Pepcid (View Usage) (Dosage: 1 Tab/daily/po) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , 59 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: angioedema. During the same period patient was treated with TAB PEPCID COMPLETE UNK (1 Tab/prn/po) (View Tab Pepcid Complete Unk Review and Tab Pepcid Complete Unk Label ), OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

6516667-8 | Blood Creatine Phosphokinase Increased
on Dec 16, 2009 Male patient from JAPAN , 20 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: blood creatine phosphokinase increased. Pepcid dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), CERCINE (View Cercine Review and Cercine Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ).

6505936-3 | Platelet Count Decreased, Purpura
on Dec 11, 2009 Female patient from JAPAN , 41 years of age, weighting 90.39 lb, was diagnosed with gastritis, pneumonia legionella and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: platelet count decreased, purpura. Pepcid dosage: . During the same period patient was treated with CIPROXAN (View Ciproxan Review and Ciproxan Label ), CLARITH (View Clarith Review and Clarith Label ), AMBISOME (View Ambisome Review and Ambisome Label ), DAUNORUBICIN HYDROCHLORIDE (View Daunorubicin Hydrochloride Review and Daunorubicin Hydrochloride Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ). Patient was hospitalized.

6502061-2 | Purpura
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: purpura on Dec 11, 2009 from JAPAN Additional patient health information: Female patient , 41 years of age, weighting 90.39 lb, was diagnosed with gastritis, pneumonia legionella and. Pepcid dosage: . During the same period patient was treated with CIPROXAN (View Ciproxan Review and Ciproxan Label ), CLARITH (View Clarith Review and Clarith Label ), AMBISOME (View Ambisome Review and Ambisome Label ), DAUNORUBICIN HYDROCHLORIDE (View Daunorubicin Hydrochloride Review and Daunorubicin Hydrochloride Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ). Patient was hospitalized.

6501617-0 | Convulsion
Adverse event was reported on Dec 07, 2009 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with odynophagia and. Location: JAPAN , 23 years of age, weighting 94.80 lb, Patient had the following side effects: convulsion. During the same period patient was treated with SEFIROM (View Sefirom Review and Sefirom Label ), CLINDAMYCIN PHOSPHATE (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ), MEFENAMIC ACID (View Mefenamic Acid Review and Mefenamic Acid Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), BENZALIN (View Benzalin Review and Benzalin Label ), GABAPEN (View Gabapen Review and Gabapen Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).

6488046-3 | Autoimmune Hepatitis
on Nov 17, 2009 Female patient from JAPAN , 46 years of age, weighting 101.4 lb, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: autoimmune hepatitis. Pepcid dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6485262-1 | Acidosis, Completed Suicide, Hypotension, Hypothermia, Respiratory Failure, Unresponsive To Stimuli
on Nov 30, 2009 Female patient from UNITED STATES , 67 years of age, was diagnosed with suicide attempt and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, completed suicide, hypotension, hypothermia (What is hypothermia?), respiratory failure, unresponsive to stimuli. Pepcid dosage: . During the same period patient was treated with LOPERAMIDE (View Loperamide Review and Loperamide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6483923-1 | Stevens-johnson Syndrome
Patient was taking Pepcid (View Usage). Patient had the following side effects: stevens-johnson syndrome on Nov 27, 2009 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with pyrexia, cerebral haemorrhage and. Pepcid dosage: . During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ).